Atrial Echo Beats Research Articles

Diagnosis and management of phantom tachycardias based on an electrophysiologically guided approach

BackgroundNon-documented palpitations, or phantom tachycardias, are palpitations deemed to be of unknown origin after evaluation with conventional diagnostic tools, such as 12-lead electrocardiogram and Holter recordings. Our aim was to determine the diagnostic value of an electrophysiologic study (EPS) and its role in the management of patients presenting with non-documented palpitations. MethodsWe performed EPS in 78 consecutive patients with repeatable, poorly tolerated symptoms of paroxysmal, non-documented tachycardia, the absence of structural heart disease and at least one 24-h Holter recording. The duration and frequency of palpitations was registered in each patient. ResultsLong-lasting palpitations (>1 hour) were present in 15.4% of patients. Half of patients reported symptoms less often than once per week. Only 13/78 patients (16.6%) had normal EPS findings, while dual pathways at the AV node ± echo beats were identified in another 13 patients without inducible tachycardia. At least one tachycardia event was induced in 52 patients (66.6%). AVNRT was provoked in 32 patients (41.2%). Ablation was performed in 14/52 patients with inducible tachycardia (26.9%). Slow pathway ablation was also performed in three patients with dual AV pathways and atrial echo-beats but without provoked tachycardia. Follow-up data were available in 52 patients, and 84.6% had fewer or no clinical recurrences. ConclusionsEPS is safe and of enhanced diagnostic value in patients with unexplained palpitations because only 1/6 had negative results. EPS also provided an explanation about the mechanism of arrhythmia and successfully guided the management of these patients, as well as enhanced improvement in the quality of life.

Cryoablation for AVNRT: Importance of Ablation Endpoint Criteria

For ablation of atrioventricular nodal reentrant tachycardia (AVNRT), cryoablation has been shown to be a safe alternative to radiofrequency ablation. However, previous studies have shown a higher recurrence rate with cryoablation compared to radiofrequency ablation. This study reviewed our experience using cryoablation for typical AVNRT using stringent endpoint criteria for slow pathway ablation, yet preserving the desirable safety profile of cryoablation. Seventy-five consecutive cases of typical AVNRT underwent cryoablation. Ablation of the AV nodal slow pathway was performed with the goal of eliminating tachycardia, AH jump, and retrograde atrial echo beats. The primary efficacy endpoint was freedom of recurrent supraventricular tachycardia at follow-up. Analysis of AVN characteristics, number of lesions, and complications was performed. Seventy-two (96%) patients met the primary efficacy endpoint over an average follow-up of 34.6 (12.6-68.3) months. In patients who had complete elimination of the slow pathway, there were no recurrences. The presence of an AH jump with a single retrograde echo was highly associated with a recurrence (P = 0.0001). There were no complications, including AV conduction block. The efficacy of cryoablation for management of AVNRT can be comparable to radiofrequency energy if the suggested endpoint of elimination of tachycardia, AH jump with retrograde atrial beats, is met. Prior studies evaluating cryoablation in this setting did not require this endpoint, which could have contributed to the relatively higher rate of late recurrences.

P17 Profile of rheumatoid arthritis at first visit to a tertiary rheumatology centre

Non-documented palpitations, or phantom tachycardias, are palpitations deemed to be of unknown origin after evaluation with conventional diagnostic tools, such as 12-lead electrocardiogram and Holter recordings. Our aim was to determine the diagnostic value of an electrophysiologic study (EPS) and its role in the management of patients presenting with non-documented palpitations.We performed EPS in 78 consecutive patients with repeatable, poorly tolerated symptoms of paroxysmal, non-documented tachycardia, the absence of structural heart disease and at least one 24-h Holter recording. The duration and frequency of palpitations was registered in each patient.Long-lasting palpitations (>1 hour) were present in 15.4% of patients. Half of patients reported symptoms less often than once per week. Only 13/78 patients (16.6%) had normal EPS findings, while dual pathways at the AV node ± echo beats were identified in another 13 patients without inducible tachycardia. At least one tachycardia event was induced in 52 patients (66.6%). AVNRT was provoked in 32 patients (41.2%). Ablation was performed in 14/52 patients with inducible tachycardia (26.9%). Slow pathway ablation was also performed in three patients with dual AV pathways and atrial echo-beats but without provoked tachycardia. Follow-up data were available in 52 patients, and 84.6% had fewer or no clinical recurrences.EPS is safe and of enhanced diagnostic value in patients with unexplained palpitations because only 1/6 had negative results. EPS also provided an explanation about the mechanism of arrhythmia and successfully guided the management of these patients, as well as enhanced improvement in the quality of life.

Impact of cryoablation catheter size on success rates in the treatment of atrioventricular nodal re-entry tachycardia in 160 patients with long-term follow-up

To determine the efficacy and safety of cryoablation for the treatment of atrioventricular nodal re-entry tachycardia (AVNRT). We analysed the procedural characteristics, acute success, and recurrence rates of 160 consecutive patients treated with cryoablation for the AVNRT and followed up for 18 months. Mean procedural time was 119.1 +/- 3.7 min, with an average of 4.6 +/- 0.2 Cryo lesions and an acute procedural success rate of 93%. Recurrence rates were 19 (11.9%) cases and were significantly higher in the 4 mm cryocatheter-treated group (12/59, 16.9%), compared with the 6 mm cryocatheter-treated group (9/101, 6.9%, P = 0.01). Recurrence rates were greater where slow pathway block was not achieved 8/12 (66.7%), compared with complete slow pathway block 11/129 (8.5%, P < 0.0001). Recurrence was significantly more likely if atrial echo beats were still present after cryoablation, 12/130 (9.2%) patients with no recurrence vs. 7/19 (36.8%) patients with recurrence (P < 0.0001). Cryoablation is a safe and efficacious treatment for AVNRT. Complete slow pathway block is associated with long-term success, together with the use of the larger 6 mm cryocatheter. There is always a risk of heart block with radiofrequency ablation, although this experience confirms previous findings that the risk with Cryo is zero.

Radiofrequency Ablation in Noninducible Supraventricular Tachycardia

To evaluate the efficacy and safety of slow pathway radiofrequency ablation (RFA) in patients with clinically documented but noninducible paroxysmal supraventricular tachycardia (PSVT) and dual AV nodal physiology. We studied 8 out of 142 patients referred for PSVT RFA. They had documented but noninducible PSVT, corresponding to an AV nodal reentrant tachycardia (AVNRT) and dual AV nodal physiology (evidenced by AH jump ≥ 50 msec and one or more atrial echo beats) during the electrophysiological study. The presence of an accessory pathway was excluded. There were six women, mean age of 53±14 years. RFA was performed via anatomic approach (targeting the inferoposterior region of the triangle of Koch) and mapping of the slow pathway potential. A mean of 4 ± 2 pulses were delivered, at a mean power of 34 ± 8 W. The acute outcome was 100% successful, without any echo beats or AH jumps. No arrhythmia occurred during a mean follow-up period of 19 ±3 months. Slow pathway ablation might be beneficial in patients with documented but noninducible PSVT and dual AV nodal physiology.

Atrioventricular node reentry: physiology and radiofrequency ablation.

Atrioventricular (AV) node reentry has been recognized as a clinical arrhythmia for many years. Earlier basic investigations identified a dual AV conduction system, and atrial echo beats occurred when the refractory period of the slow conduction pathway was shorter than the fast pathway. Subsequent studies in humans confirmed the concept of dual AV node physiology and AV node reentry. Slow-fast AV node reentry (anterograde conduction over the slow pathway and retrograde conduction over the fast pathway) occurs most frequently. The fast-slow and intermediate varieties are much less common. A high (> 95%) cure rate occurs with radiofrequency catheter ablation with experienced electrophysiologists. Most electrophysiologists prefer the posterior approach, which results in absence or very poor conduction over the slow AV node pathway: the PR interval is minimally changed. This approach is highly successful for all three forms of AV node reentry and associated with a 1%-2% incidence of heart block in most experienced laboratories.

Radiofrequency ablation of slow pathway in patients with atrioventricular nodal reentrant tachycardia. Do arrhythmia recurrences correlate with persistent slow pathway conduction or site of successful ablation?

Residual slow pathway conduction in the form of persistent jump in the atrioventricular (AV) conduction time or atrial echo beats is a common finding after successful radiofrequency (RF) ablation of the slow pathway in patients with AV nodal reentrant tachycardia (AVNRT). Sites of successful RF ablation of the slow pathway may be located anteriorly in the tricuspid annulus (cephalad to the coronary sinus os) or posteriorly (at, within, or caudal to the coronary sinus os). The aim of this study was to investigate whether arrhythmia recurrences correlate with persistent slow pathway conduction or site of successful ablation. Among 55 patients with symptomatic AVNRT having RF ablation, 23 patients (42%) (group 1) had evidence of persistent dual AV nodal pathway physiology and/or echo beats, whereas in 32 patients (group 2), slow pathway conduction had been completely eliminated. With regard to ablation sites, 14 patients (25%) (group A) had their slow pathway successfully ablated at an inferoposterior site, whereas in 41 patients (group B), the ablation site was located anteriorly to the coronary sinus os. The study patients included 17 men and 38 women, aged 37 +/- 18 years. The electrophysiological study and RF ablation were performed in a single session in 50 patients (91%). After the first session, the technique was successful in all patients (100%), with elimination of AVNRT and without affecting AV conduction. A mean of 9 +/- 6 lesions were applied. The total procedure time averaged 4 +/- 1 hours. Fluoroscopy time was 41 +/- 25 minutes. Except for transient AV block in 1 patient, no other complications occurred. Over 12 +/- 8 months, a total of 7 patients (13%) had recurrence of AVNRT, and 6 of them underwent successful repeat slow pathway RF ablation. Recurrence rate was 9% (2 patients) for group 1, with persistent jump or echo beats, and 16% (5 patients) for group 2, without residual slow pathway conduction (P = NS). Five of the recurrences (71%) were noted in group A and 2 in group B. Thus, the recurrence rate was 36% for group A (5 of 14 patients), with posterior ablations, and 5% for group B (2 of 41 patients), with anterior sites of successful RF ablation (P < .05). After successful RF ablation of the slow pathway in patients with AVNRT, residual slow pathway conduction does not correlate with clinical tachycardia recurrences. However, the site of successful RF ablation of the slow pathway does correlate with arrhythmia recurrences. More recurrences are observed when the site is located inferoposteriorly, at or below the os of the coronary sinus, as compared with medial and anterior locations of the ablation site.

Feasibility of closed heart discrete cryomodification of atrioventricular conduction: Electrophysiologic effects in the canine heart

Discrete cryosurgical modification of atrioventricular conduction abolishes refractory atrioventricular node reentry tachycardia with preservation of antegrade atrioventricular nodal conduction. This procedure presently requires cardiopulmonary bypass. To modify atrioventricular conduction without cardiac surgery, we evaluated the electrophysiologic effects of cryolesions applied to the peri-nodal area in the closed heart in 16 dogs before operation, during cryothermic exposure, and at 1 hour and 3 hours after operation. The electrophysiologic effects were evaluated in 10 of the 16 dogs at 2 weeks postoperatively. The dogs were given general anesthetics, and a cryoprobe was introduced into the right atrial cavity through the right atrial appendage. Cryolesions (-60 degrees C) were placed at nine to eleven preselected points around the perinodal area guided by electrodes on the tip of the cryoprobe. Postoperatively, there were significant prolongations of the atrio-His interval, Wenckebach's point, effective refractory period, and functional refractory period of the atrioventricular node. Atrial echo beats were eliminated or decreased in frequency. There was also a significant increase in retrograde ventriculoatrial conduction time. In the long-term observation period the atrio-His intervals remained significantly prolonged in comparison with the preoperative values, the atrial echoes progressively decreased, and ventriculoatrial conduction was absent in five of seven animals. A serendipitous atrioventricular node reentry tachycardia that was inducible in one animal with dual atrioventricular node conduction pathways was successfully eliminated and was not inducible at 2 weeks postoperatively. Complete atrioventricular block occurred during attempts to produce greater atrio-His prolongation in three of the 16 animals and persisted in two for the 2-week period of observation. Closed heart intracardiac cryomodification of atrioventricular conduction is feasible, with the cryoprobe in normothermic blood, producing changes in atrioventricular conduction similar to the open cardiac procedure.

AV nodal reentrant tachycardia with mahaim fiber conduction.

Paroxysmal tachycardia with widened QRS complexes was found in a 46-year-old woman. In sinus rhythm, the patient had electrocardiographic evidence of type B preexcitation with a left bundle branch block pattern. The resting PR interval (160 msec) and A-H interval (100 msec) were within normal limits, but the H-V interval (10 msec) was abnormally short. Programmed atrial extrastimuli at progressively shorter coupling intervals resulted in sudden prolongation of the A-H interval from 120 msec to 250 msec, and the His bundle activities became incorporated just after initiation of the QRS complexes. The QRS morphology was changed but the change was minimal, and atrial echo beats or sustained tachycardia with wide and preexcited QRS complexes were elicited. It is postulated that the site of reentry is within the AV node with preexcitation occurring as the result of conduction in an anomalous nodoventricular pathway.

Proarrhythmic and antiarrhythmic effects of intravenous prostacyclin in man.

Prostacyclin (PGI2) has been shown to reduce the occurrence of experimental ventricular arrhythmias. To assess potential beneficial effects in man, the electrophysiological action of PGI2 was studied in 16 non medicated patients. The protocol used in incremental pacing and programmed stimulation in the right atrium and ventricle. This protocol and measurement of effective refractory periods (ERP) were performed before and during the injection of 2.5, 5 and 10 ng kg-1 min-1 of PGI2. The atrial functional refractory period decreased significantly (P less than 0.05); PGI2 had no influence on the occurrence of inducible non-sustained (NS) atrial tachycardias and was responsible for the occurrence of 2 non-sustained atrial tachycardias in 8 patients with inducible atrial echo beats under basal conditions. Thirteen patients did not have inducible ventricular tachycardia (VT) under basal conditions. Non-sustained VT was induced after PGI2 in 4 of them but in only 1 of them after the administration of propranolol. Three patients had inducible VT under basal conditions (1 non-sustained, 2 sustained VT). PGI2 did not prevent the occurrence of VT (1 non-sustained, 1 sustained VT), except in 1 patient with ischaemic-related VT, who had non-sustained VT after PGI2. In conclusion, PGI2 does not seem to have a cardiac antiarrhythmic effect and may increase the atrial and ventricular repetitive response. This effect could be related to an increase of adrenergic tone.

Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia

Using His bundle electrograms, incremental ventricular pacing and the ventricular extrastimulus (V 2) technique, the effects of intravenous verapamil, 0.2 mg/kg, on retrograde atrioventricular (AV) nodal conduction during ventricular pacing, premature ventricular stimulation (H 2A 2 interval) and paroxysmal supraventricular tachycardia (SVT) (H-Ae interval) were evaluated In 11 patients with AV nodal reentrant tachycardia. During the control study, SVT could be induced in all 11 patients. After verapamil administration, SVT or atrial echo beats could be induced in 5 patients. Verapamil produced ventriculoatrial (VA) block at a longer cycle length than that during the control study in 10 of 11 patients (295 ± 27 vs 352 ± 40 ms, p < 0.01), but prolonged H 2A 2 interval in only 5 of 11 patients (37 ± 6 vs 60 ± 31 ms, p <0.05). In all 5 patients with persistence of inducible SVT or atrial echo beats after verapamil treatment, the H-Ae interval remained unchanged even though in 4 of these 5 patients VA conduction time or H 2A 2 interval was prolonged. Correlation between the paced cycle length which Induced VA block, the shortest V 1H 2 interval achieved during premature ventricular stimulation and the cycle length of SVT revealed that in all instances in which verapamil induced VA block at a longer cycle length than in controls but did not prolong H 2A 2 or H-Ae interval, the shortest V 1H 2 interval and the cycle length of SVT (H-H interval) were significantly longer than the ventricular paced cycle length which produced VA block. Our findings suggest that in AV nodal reentry, the retrograde limb is formed by the atrioventricular nodal-like structure, and the dissimilar effects of verapamil on VA conduction, H 2A 2 interval and H-Ae interval appear to be a result of our inability to achieve V 1H 2 and H-H intervals comparable to the paced cycle length that induced VA block.

Effect of nifedipine and AQ-A 39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant tachycardia.

The effects of two drugs that apparently block slow inward current--nifedipine and the new compound AQ-A 39--were studied on the isolated sinoatrial (SA) and atrioventricular (AV) nodes of the rabbit heart using intracellular microelectrodes. Nifedipine and AQ-A 39 both slowed the sinus rate associated with a decrease in the rate of diastolic depolarisation. Conduction through the AV node was consistently impaired; this effect was enhanced with increasing atrial rates or with decreasing coupling intervals of premature beats. The action potential amplitude was significantly reduced in SA nodal and upper (AN) AV nodal fibres but was not significantly affected in lower (NH) AV nodal and in atrial fibres. The maximum diastolic potential showed little or no alteration. In all fibre types studied, the action potential duration was shortened with nifedipine but was significantly prolonged with AQ-A 39. Prevention of AV nodal reentrant tachycardia by nifedipine was related to an increase in the effective refractory period of the AV node. AQ-A 39 prevented the tachycardia by both slowing of AV nodal conduction and by prolongation of action potential duration in the AV nodal and atrial compartments of the reentrant circuit associated with the appearance of different gap phenomena of the AV conduction. The maximum possible A-H interval was, however, not shortened by either drug and single atrial echo beats could still be initiated. The results suggest that nifedipine and AQ-A 39 both have a direct depressant action on the slow inward current-dependent electrical activity of the SA and AV node but have opposite effects on the repolarisation phase resulting in different antiarrhythmic mechanisms.

Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction.

The electrophysiological effects of intravenous administration of disopyramide (1.5 mg/kg) were studied in 26 patients with sinus node dysfunction (SND). Disopyramide shortened spontaneous cycle length (SCL) in 12 patients and lengthened it in 4. Maximum sinus node recovery time (max SRT) was prolonged in 9 patients and shortened in 6. Estimated sinoatrial conduction time (SACT) was prolonged in 4 and shortened in 4 out of 10 patients in whom this measurement was possible. However, these changes were not statistically significant. Neither were there any significant changes in PA and AH intervals nor refractory periods of the AV node. HV intervals and refractory periods of the atrium at matched cycle length were significantly lengthened. Atrial echo beats and atrial premature beats disappeared in 7 of 12 patients treated with disopyramide. In all of these 7 patients atrial refractory period were increased. Thus, the disappearance of atrial echo beats and atrial premature beats was thought to be due to a prolonged atrial refractoriness. In 4 patients who had supraventricular arrhythmias without having either marked prolongation of max SRT or episodes of syncope, disopyramide was administered orally for a long term, during which these arrhythmias and symptoms disappeared and sinus rate increased. These results suggest that disopyramide is useful in patients with SND and supraventricular arrhythmias.

Induction of atrioventricular nodal reentrant tachycardia after atropine: Report of five cases

After intravenous administration of 0.5 mg of atropine sustained atrioventricular (A-V) nodal reentrant tachycardia could be produced in five patients who had no prior historical or electrocardiographic evidence of supraventricular tachycardia. During the control period single atrial echo beats could be demonstrated in four of the five patients, but no instance of sustained tachycardia occurred. Atropine, known to enhance A-V nodal conduction, allowed achievement of longer A-H intervals (Case 1) and provided the necessary balance of conduction and refractoriness within the A-V nodal reentrant pathways (Cases 1 to 5) to sustain A-V nodal reentry in these patients.

Intraventricular conduction delay as a determinant of atrial echo beats.

Re-entry within the atrioventricular (A-V) node is a common cause of atrial echo beats and paroxysmal atrial tachycardia. This report deals with observations made in four patients in whom the determining factor for atrial echo beats appeared to be a critical conduction delay occurring within the His-Purkinje system and not within the A-V node. The evidence in support of this conclusion is as follows: 1) at a constant A-V nodal delay, echo beats only occurred when a critical His-Purkinje delay was reached; 2) in the presence of different intraventricular conduction times, atrial echoes were dependent on a requisite His-Purkinje conduction delay; 3) at variable A-V nodal conduction times, echo beats appeared only when a requisite delay in His-Purkinje conduction developed; 4) at a constant premature coupling interval atrial echo beats could be abolished when refractoriness within the His-Purkinje system was decreased by decreasing the cycle length of the basic drive; and 5) at constant A-V nodal conduction times, a reciprocal relationship existed between the magnitude of the His-Purkinje delay and the "echo interval" defined as the interval between the onset of ventricular depolarization and the echo beat.

Electrophysiologic studies in the syndrome of short P-R interval, normal QRS complex

Eighteen subjects with a short P-R interval (<0.12 second) and normal QRS complex were studied by means of His bundle recordings and programmed atrial premature depolarizations. Eight subjects had a history of supraventricular tachycardia. During sinus rhythm, the A-H interval was less than or at the lower limits of normal values (45 to 80 msec), and the H-V interval was normal (30 to 50 msec). Atrial pacing at rates of up to 160/min produced 3 types of responses. Thirteen subjects showed a progressive increase in A-H interval similar to that of normal subjects but to a lesser degree. Three subjects showed an initial increase at low pacing rates, followed by a plateau response and further increase at higher rates. Two subjects showed no significant increase in the A-H interval. In 6 of 8 subjects with supraventricular tachycardia, atrial premature depolarizations produced atrial echo beats and sustained supraventricular tachycardia in 4, indicating atrioventricular (A-V) nodal reentry as the mechanism for the supraventricular tachycardia. In 10 subjects, refractory periods of the various components of the A-V conducting system were found to be similar to those of subjects with a normal P-R interval. The data suggest the following possible explanations for the short P-R interval: (1) total or partial bypass of the A-V node; (2) an anatomically small A-V node; (3) a short or rapidly conducting intranodal pathway; or (4) isorhythmic A-V dissociation.

Three atrioventricular pathways: Reciprocating tachycardia with alternation of conduction times

A case of intermittent Wolff-Parkinson-White syndrome showed first-degree anterograde block, atrial echo beats, and runs of reciprocating tachycardia. During the tachycardia, anterograde conduction times were alternately long and short (“alternation of conduction times”). Three A-V pathways must be postulated to explain this arrhythmia: one ectopic and two within the A-V node. The significance of dual and triple A-V pathway is explored. The intermittent failure of the bypass to pre-excite the ventricles is the result, not of block, but of an impedance mismatch between the small bypass filament and the large mass of the ventricular myocardium. The junction between the bypass and the atrium presents no such mismatch, permitting consistent retrograde atrial activation. Both intermittent anterograde failure and regular retrograde excitation are essential to the initiation and maintenance of the tachycardia, which is terminated by the development of second-degree block within one of the two A-V nodal pathways.

Ventricular Echo Beats in the Human Heart Elicited by Induced Ventricular Premature Beats

In three patients, all having as their only hemodynamic abnormality an elevated cardiac index at rest, ventricular echo beats could be elicited by ventricular premature beats induced during regular driving of the ventricle. The occurrence of ventricular echo beats was in each case limited to a small delay-range of the premature beat. Retardation of retrograde conduction of the premature ventricular impulse to the atria appeared to be a necessary condition for the initiation of the echo phenomenon. One of the patients had retardation of antegrade A-V conduction of sinus and premature atrial beats. Atrial echo beats could be elicited in this case. The genesis of the ventricular echo phenomenon in these cases could be explained by the dual conducting system theory.

Atrial echo beats in the human heart elicited by induced atrial premature beats.

In a patient with atrial septal defect and incomplete right bundle-branch block atrial echo beats were observed after atrial premature beats, induced with a gradually decreasing delay during regular driving of the atrium. The time relations of these atrial echo beats could be accurately defined. Considerable prolongation of the atrioventricular (A-V) conduction of the premature atrial response was found to be a necessary condition for the occurrence of atrial reciprocation, which was restricted to small and very circumscript delay ranges. Three types of atrial echo responses could be discerned. The concept of a dual A-V conduction system was not sufficient to explain the genesis of these three types. The assumption of a third pathway in the upper part of the A-V node was needed. Arguments in favor of a longitudinal dissociation of one of the two pathways postulated in the concept of dual A-V transmission were given.

Electrical aspects of human cardiac activity: a clinical-physiological approach to excitation and stimulation.

A description of total excitation of the adult human heart is given. Atrial testing stimuli were used for the analysis of the genesis of attacks of supraventricular tachycardia in the W.P.W. syndrome; the short PR, normal QRS-syndrome; incomplete left bundle branch block; atrial echo beats; and gap in atrioventricular conduction. The E.C.G. in cardiomyopathy and the value of the intrinsicoid deflection in precordial leads are briefly discussed.